Angiocrine Bioscience reported raising $2.1 Million in an initial SEC Form D filing, from an offering of $3 Million
Round Type
Venture
San DiegoBiotechnologyQuick answer
Angiocrine Bioscience raised $2.1 Million in a funding round, dated August 21, 2025. Angiocrine Bioscience is based in San Diego, California, United States.
- How much did Angiocrine Bioscience raise?
- Angiocrine Bioscience raised $2.1 Million in a funding round on August 21, 2025.
- What does Angiocrine Bioscience do?
- Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients..
- Where is Angiocrine Bioscience based and how big is it?
- Angiocrine Bioscience is based in San Diego, California, United States. Fundz records about 16 employees.
- Who are the decision-makers at Angiocrine Bioscience?
- Fundz holds 1 contact at Angiocrine Bioscience, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Angiocrine Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Trogenix raised $95M (Series A) on October 5, 2025.
- NeuroTrigger raised $725K (Seed) on October 5, 2025.
- Innventure raised $9.8M on October 3, 2025.
- Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
- Kihealth raised $5M (Seed) on October 2, 2025.
- OncoC4 raised $50M (Series B) on October 2, 2025.
Who to call at Angiocrine Bioscience, and when
A new round usually means Angiocrine Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Angiocrine Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Angiocrine Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Angiocrine Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Angiocrine Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Angiocrine Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.